My Account

Risk Management
Workers Comp & Safety
Employee Benefits
International
People
Events
BI Intelligence
Magazine
- Current Issue
- Past Issues
DEI Institute

Recent Quotes

View Full List

My Watchlist

Indicators

Business Insurance Index

Markets:

Overview

News

Currencies

International

Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

8.651 +0.901 (+11.63%)

Streaming Delayed Price Updated: 2:00 PM EST, Jan 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

65 66 Next >

Where Will Novavax Be in 3 Years? ↗

November 11, 2023

Novavax shares have plunged from early pandemic highs.

Via The Motley Fool

Novavax Prepares Further Cost Cuts To Better Align With Demand-Challenged COVID-19 Vaccine Market ↗

November 09, 2023

Novavax Inc (NASDAQ: NVAX) reported Q3 revenue of $187 million, compared to $735 million in the same period in 2022, beating the

Via Benzinga

Wall Street To Snap Longest Winning Streak Since 2021 Today? Earnings, Bond Yields In Focus Ahead Of Powell's Speech ↗

November 09, 2023

The stock market’s momentum appears to be waning, and futures suggest a mixed opening for Thursday. Earnings reports have generally been positive, with companies like Walt Disney Co.

Via Benzinga

Novavax's Earnings: A Preview ↗

November 08, 2023

Via Benzinga

The Fall Vaccination Season Is Here. Is Novavax a Buy? ↗

October 12, 2023

Novavax shares have declined 28% this year.

Via The Motley Fool

Down 75% From Its High, Has Novavax Stock Become Too Cheap to Pass Up? ↗

November 02, 2023

It won't be easy for this company to win back investors, as the business faces some big challenges.

Via The Motley Fool

Moderna Beats Sales Forecasts, But Light Guidance Could Rattle Shares ↗

November 02, 2023

The company issued below-consensus sales views for 2023 and 2024.

Via Investor's Business Daily

7 Dangerous Stocks to Avoid No Matter What ↗

November 01, 2023

Despite arguments to the contrary, stay away from each of these seven stocks to avoid, as each carries substantial downside risk.

Via InvestorPlace

Top 6 Nasdaq Short Squeeze Play Stocks ↗

October 25, 2023

The following are some heavily shorted tech stocks that may be worth considering.

Via Talk Markets

Pfizer Reportedly Hikes Paxlovid Price To $1,390 — More Than Double What The Government Paid ↗

October 19, 2023

The transition to the commercial market is planned for 2024 and could bolster sales.

Via Investor's Business Daily

10 Health Care Stocks Whale Activity In Today's Session ↗

October 18, 2023

Via Benzinga

Do These 5 Words From Pfizer Mean Trouble for Novavax? ↗

October 17, 2023

Coronavirus vaccine sales could represent recurrent annual revenue for Novavax and rivals.

Via The Motley Fool

Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

October 16, 2023

Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday.

Via Benzinga

Bitcoin's ETF Approval Rumor, Pfizer Slashes Annual Outlook, Activist Shareholder Shakes Up News Corp's Status Quo: Today's Top Stories ↗

October 16, 2023

Benzinga Bitcoin Spiked On False ETF Approval Rumor

Via Benzinga

Topics ETFs

Moderna, BioNTech Lead Covid Sell-Off After Pfizer Slashes Its Outlook By $9 Billion ↗

October 16, 2023

Pfizer cut about $9 billion from its sales expectations for Covid products this year.

Via Investor's Business Daily

Novavax Faces Setback, European Authority Delays Decision On Variant-Tailored COVID-19 Vaccine ↗

October 16, 2023

Novavax Inc (NASDAQ: NVAX) faces a setback as the European Medicines Agency (EMA) delays a decision on its variant-tailored COVID-19 vaccine.

Via Benzinga

The 10 Most Shorted Stocks Include 3 Tesla Rivals, But Not TSLA ↗

October 16, 2023

Some big 2023 winners are shorted heavily, including two AI plays.

Via Investor's Business Daily

Topics Artificial Intelligence

US Stocks On Track For A Strong Start To Week, Buoyed By Earnings Optimism: Analyst Flags 13-14% Upside As Bull Market Enters Its Second Year ↗

October 16, 2023

US stocks appear on track to start higher on Monday as traders look ahead to the earnings season to serve as upside catalyst.

Via Benzinga

BioNTech, Moderna And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

October 16, 2023

U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Is Novavax Stock a Buy Now? ↗

October 16, 2023

Is this company just a pandemic stock?

Via The Motley Fool

Novavax (NVAX) Stock Slides Despite Vaccine Availability ↗

October 13, 2023

Although Novavax’s non-mRNA vaccine being available broadly represents good news, NVAX stock suffered due to unfavorable timing.

Via InvestorPlace

AZZ, VOXX International And Other Big Stocks Moving Higher On Wednesday ↗

October 11, 2023

U.S. stocks traded higher Wednesday, with the Dow Jones gaining around 100 points. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

October 11, 2023

Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in...

Via Benzinga

The COVID Vaccine Market Is Changing Dramatically. Do Vaccine Stocks Still Make Good Investments? ↗

October 11, 2023

Vaccine revenue may have slipped but could still represent billions of dollars for these companies.

Via The Motley Fool

Timing Favors Novavax's Delayed Approval, Arrival Ahead of Peak COVID Vaccine Demand ↗

October 09, 2023

Last week, Novavax Inc (NASDAQ: NVAX) received FDA authorization for its updated COVID-19 vaccine, targeting the omicron subvariant XBB.1.5 in

Via Benzinga

3 Pharma Stocks to Dump Before the Damage Is Done ↗

October 08, 2023

There's never a shortage of pharma stocks to sell due to the nature of the sector, especially when compounded by current fears.

Via InvestorPlace

This Could be Novavax's Big Opportunity ↗

October 07, 2023

Novavax has lagged behind bigger rivals in the vaccine market.

Via The Motley Fool

Did Moderna Just Jump Ahead of Rivals in a Potential Billion-Dollar Market? ↗

October 06, 2023

Moderna, Pfizer, and Novavax all are working on combined vaccine candidates.

Via The Motley Fool

Why Novavax Stock Fell Today ↗

October 04, 2023

Novavax, Inc. (NASDAQ: NVAX) shares are trading lower Wednesday amid a pullback in the stock, which gained Tuesday after the FDA granted Emergency Use Authorization for the company's updated...

Via Benzinga

Novavax's COVID-19 Shot Just In Time, Optimism Surrounds As Demand Picks Up Momentum ↗

October 04, 2023

Tuesday, the FDA granted an emergency use nod to Novavax Inc's (NASDAQ: NVAX) COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) (NVX-CoV2601) for active immunization to prevent COVID-19 in

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

65 66 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.

Information

About Us
Contact
Advertise
Privacy Policy
Terms & Condition